Xiaoxiao Alice Lu
Director, J&J Innovative Medicine, New Products And Ira @ Johnson & Johnson
About Xiaoxiao Alice Lu
Xiaoxiao Alice Lu is the Director of J&J Innovative Medicine, New Products and IRA at Johnson & Johnson, where she leads the RWE/HEOR strategy for early pipeline assets in hematology. She has a background in epidemiology and health economics, with previous roles at the FDA and Medtronic, and holds multiple degrees in public health and medicine.